INT J CLIN EXP MED 润色咨询

International Journal of Clinical and Experimental Medicine

出版年份:暂无数据 年文章数:62670 投稿命中率: 开通期刊会员,数据随心看

出版周期:Monthly 自引率:4.2% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=600644, encodeId=d29b600644e2, content=IJCEM会被踢吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200629/27edc3ca58794e0c8e3c7e54ded4a17a/1acf852649de425fbaf8af3ae4bc5b7b.jpg, createdBy=d8905201258, createdName=1473ceadm69(暂无昵称), createdTime=Wed May 27 13:23:11 CST 2020, time=2020-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586463, encodeId=99b058646305, content=被IJCEP拒了让转投这个,请问这俩差别大吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=186, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=17265265904, createdName=148110afm22暂无昵称, createdTime=Thu Mar 12 00:00:00 CST 2020, time=2020-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=901957, encodeId=478590195ec6, content=这个杂志录用了可以加急发吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=61ab1740098, createdName=呦宝贝, createdTime=Tue Nov 24 21:38:24 CST 2020, time=2020-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584635, encodeId=5a8a5846358e, content=被拒了,自己感觉另一篇差一些的,还被另个高一些的杂志接收了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/zoga7gvBpRvONqSypxjq5Adv6Mac2WEIKxV2jeVDxdZPtrLtlRQnX2iaWwpONcbXdmXqYqATkNiamEzUyNpaH52g/132, createdBy=f4ce1700659, createdName=daidiu, createdTime=Wed Feb 12 00:00:00 CST 2020, time=2020-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=913525, encodeId=2eea9135259b, content=投稿命中不容易, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210104/294dbbdf6b8c42efb140d9e70f3d35e6/85df95e80e0d44b8a95559af8d6adc7c.jpg, createdBy=37b35449803, createdName=dajunma, createdTime=Mon Jan 04 10:39:01 CST 2021, time=2021-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1179233, encodeId=05e311e923329, content=偏重的研究方向:肿瘤<br>经验分享:2021年《国际期刊预警名单(试行)》正式发布。 International Journal of Clinical and Experimental Medicine (IJCEM)已不在该预警名单中。 具体内容请参照https://mp.weixin.qq.com/s/dEIsgG3tCZRoWQBZ8UEJQA, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6e982088871, createdName=agile, createdTime=Fri Dec 31 12:04:23 CST 2021, time=2021-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=944703, encodeId=090d944e0366, content=今年的第一期第二期文章还会被收录吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c0e2492369, createdName=1247f785m03(暂无昵称), createdTime=Tue Mar 02 11:16:07 CST 2021, time=2021-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582525, encodeId=3abb5825252f, content=我,不过文章数据确实不行。有没有知道被这个拒了之后还能投哪里<span class="quote">198syB63031(暂无昵称) 2019-12-21 发表::<br>有没有被这个杂志拒稿过的?</span>, beContent=198syB63031(暂无昵称) 2019-12-21 发表:: 有没有被这个杂志拒稿过的?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80c11717007, createdName=relic to Vivian827a006f, createdTime=Wed Jan 01 23:01:00 CST 2020, time=2020-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=911072, encodeId=c9509110e210, content=这个杂志PMC和Pubmed检索不到影响考博晋升吗,想问, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=54045173478, createdName=146e00b0m22(暂无昵称), createdTime=Sat Dec 26 12:38:39 CST 2020, time=2020-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=905359, encodeId=ed6090535948, content=online厚要多久才能开到检索证明, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200629/27edc3ca58794e0c8e3c7e54ded4a17a/1acf852649de425fbaf8af3ae4bc5b7b.jpg, createdBy=d8905201258, createdName=1473ceadm69(暂无昵称), createdTime=Sun Dec 06 10:10:03 CST 2020, time=2020-12-06, status=1, ipAttribution=)]
    2020-05-27 1473ceadm69(暂无昵称)

    IJCEM会被踢吗

    6

    展开6条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=600644, encodeId=d29b600644e2, content=IJCEM会被踢吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200629/27edc3ca58794e0c8e3c7e54ded4a17a/1acf852649de425fbaf8af3ae4bc5b7b.jpg, createdBy=d8905201258, createdName=1473ceadm69(暂无昵称), createdTime=Wed May 27 13:23:11 CST 2020, time=2020-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586463, encodeId=99b058646305, content=被IJCEP拒了让转投这个,请问这俩差别大吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=186, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=17265265904, createdName=148110afm22暂无昵称, createdTime=Thu Mar 12 00:00:00 CST 2020, time=2020-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=901957, encodeId=478590195ec6, content=这个杂志录用了可以加急发吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=61ab1740098, createdName=呦宝贝, createdTime=Tue Nov 24 21:38:24 CST 2020, time=2020-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584635, encodeId=5a8a5846358e, content=被拒了,自己感觉另一篇差一些的,还被另个高一些的杂志接收了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/zoga7gvBpRvONqSypxjq5Adv6Mac2WEIKxV2jeVDxdZPtrLtlRQnX2iaWwpONcbXdmXqYqATkNiamEzUyNpaH52g/132, createdBy=f4ce1700659, createdName=daidiu, createdTime=Wed Feb 12 00:00:00 CST 2020, time=2020-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=913525, encodeId=2eea9135259b, content=投稿命中不容易, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210104/294dbbdf6b8c42efb140d9e70f3d35e6/85df95e80e0d44b8a95559af8d6adc7c.jpg, createdBy=37b35449803, createdName=dajunma, createdTime=Mon Jan 04 10:39:01 CST 2021, time=2021-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1179233, encodeId=05e311e923329, content=偏重的研究方向:肿瘤<br>经验分享:2021年《国际期刊预警名单(试行)》正式发布。 International Journal of Clinical and Experimental Medicine (IJCEM)已不在该预警名单中。 具体内容请参照https://mp.weixin.qq.com/s/dEIsgG3tCZRoWQBZ8UEJQA, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6e982088871, createdName=agile, createdTime=Fri Dec 31 12:04:23 CST 2021, time=2021-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=944703, encodeId=090d944e0366, content=今年的第一期第二期文章还会被收录吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c0e2492369, createdName=1247f785m03(暂无昵称), createdTime=Tue Mar 02 11:16:07 CST 2021, time=2021-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582525, encodeId=3abb5825252f, content=我,不过文章数据确实不行。有没有知道被这个拒了之后还能投哪里<span class="quote">198syB63031(暂无昵称) 2019-12-21 发表::<br>有没有被这个杂志拒稿过的?</span>, beContent=198syB63031(暂无昵称) 2019-12-21 发表:: 有没有被这个杂志拒稿过的?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80c11717007, createdName=relic to Vivian827a006f, createdTime=Wed Jan 01 23:01:00 CST 2020, time=2020-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=911072, encodeId=c9509110e210, content=这个杂志PMC和Pubmed检索不到影响考博晋升吗,想问, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=54045173478, createdName=146e00b0m22(暂无昵称), createdTime=Sat Dec 26 12:38:39 CST 2020, time=2020-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=905359, encodeId=ed6090535948, content=online厚要多久才能开到检索证明, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200629/27edc3ca58794e0c8e3c7e54ded4a17a/1acf852649de425fbaf8af3ae4bc5b7b.jpg, createdBy=d8905201258, createdName=1473ceadm69(暂无昵称), createdTime=Sun Dec 06 10:10:03 CST 2020, time=2020-12-06, status=1, ipAttribution=)]
    2020-03-12 148110afm22暂无昵称

    被IJCEP拒了让转投这个,请问这俩差别大吗

    5

    展开5条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=600644, encodeId=d29b600644e2, content=IJCEM会被踢吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200629/27edc3ca58794e0c8e3c7e54ded4a17a/1acf852649de425fbaf8af3ae4bc5b7b.jpg, createdBy=d8905201258, createdName=1473ceadm69(暂无昵称), createdTime=Wed May 27 13:23:11 CST 2020, time=2020-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586463, encodeId=99b058646305, content=被IJCEP拒了让转投这个,请问这俩差别大吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=186, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=17265265904, createdName=148110afm22暂无昵称, createdTime=Thu Mar 12 00:00:00 CST 2020, time=2020-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=901957, encodeId=478590195ec6, content=这个杂志录用了可以加急发吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=61ab1740098, createdName=呦宝贝, createdTime=Tue Nov 24 21:38:24 CST 2020, time=2020-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584635, encodeId=5a8a5846358e, content=被拒了,自己感觉另一篇差一些的,还被另个高一些的杂志接收了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/zoga7gvBpRvONqSypxjq5Adv6Mac2WEIKxV2jeVDxdZPtrLtlRQnX2iaWwpONcbXdmXqYqATkNiamEzUyNpaH52g/132, createdBy=f4ce1700659, createdName=daidiu, createdTime=Wed Feb 12 00:00:00 CST 2020, time=2020-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=913525, encodeId=2eea9135259b, content=投稿命中不容易, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210104/294dbbdf6b8c42efb140d9e70f3d35e6/85df95e80e0d44b8a95559af8d6adc7c.jpg, createdBy=37b35449803, createdName=dajunma, createdTime=Mon Jan 04 10:39:01 CST 2021, time=2021-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1179233, encodeId=05e311e923329, content=偏重的研究方向:肿瘤<br>经验分享:2021年《国际期刊预警名单(试行)》正式发布。 International Journal of Clinical and Experimental Medicine (IJCEM)已不在该预警名单中。 具体内容请参照https://mp.weixin.qq.com/s/dEIsgG3tCZRoWQBZ8UEJQA, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6e982088871, createdName=agile, createdTime=Fri Dec 31 12:04:23 CST 2021, time=2021-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=944703, encodeId=090d944e0366, content=今年的第一期第二期文章还会被收录吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c0e2492369, createdName=1247f785m03(暂无昵称), createdTime=Tue Mar 02 11:16:07 CST 2021, time=2021-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582525, encodeId=3abb5825252f, content=我,不过文章数据确实不行。有没有知道被这个拒了之后还能投哪里<span class="quote">198syB63031(暂无昵称) 2019-12-21 发表::<br>有没有被这个杂志拒稿过的?</span>, beContent=198syB63031(暂无昵称) 2019-12-21 发表:: 有没有被这个杂志拒稿过的?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80c11717007, createdName=relic to Vivian827a006f, createdTime=Wed Jan 01 23:01:00 CST 2020, time=2020-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=911072, encodeId=c9509110e210, content=这个杂志PMC和Pubmed检索不到影响考博晋升吗,想问, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=54045173478, createdName=146e00b0m22(暂无昵称), createdTime=Sat Dec 26 12:38:39 CST 2020, time=2020-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=905359, encodeId=ed6090535948, content=online厚要多久才能开到检索证明, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200629/27edc3ca58794e0c8e3c7e54ded4a17a/1acf852649de425fbaf8af3ae4bc5b7b.jpg, createdBy=d8905201258, createdName=1473ceadm69(暂无昵称), createdTime=Sun Dec 06 10:10:03 CST 2020, time=2020-12-06, status=1, ipAttribution=)]
    2020-11-24 呦宝贝

    这个杂志录用了可以加急发吗?

    5

    展开5条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=600644, encodeId=d29b600644e2, content=IJCEM会被踢吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200629/27edc3ca58794e0c8e3c7e54ded4a17a/1acf852649de425fbaf8af3ae4bc5b7b.jpg, createdBy=d8905201258, createdName=1473ceadm69(暂无昵称), createdTime=Wed May 27 13:23:11 CST 2020, time=2020-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586463, encodeId=99b058646305, content=被IJCEP拒了让转投这个,请问这俩差别大吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=186, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=17265265904, createdName=148110afm22暂无昵称, createdTime=Thu Mar 12 00:00:00 CST 2020, time=2020-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=901957, encodeId=478590195ec6, content=这个杂志录用了可以加急发吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=61ab1740098, createdName=呦宝贝, createdTime=Tue Nov 24 21:38:24 CST 2020, time=2020-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584635, encodeId=5a8a5846358e, content=被拒了,自己感觉另一篇差一些的,还被另个高一些的杂志接收了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/zoga7gvBpRvONqSypxjq5Adv6Mac2WEIKxV2jeVDxdZPtrLtlRQnX2iaWwpONcbXdmXqYqATkNiamEzUyNpaH52g/132, createdBy=f4ce1700659, createdName=daidiu, createdTime=Wed Feb 12 00:00:00 CST 2020, time=2020-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=913525, encodeId=2eea9135259b, content=投稿命中不容易, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210104/294dbbdf6b8c42efb140d9e70f3d35e6/85df95e80e0d44b8a95559af8d6adc7c.jpg, createdBy=37b35449803, createdName=dajunma, createdTime=Mon Jan 04 10:39:01 CST 2021, time=2021-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1179233, encodeId=05e311e923329, content=偏重的研究方向:肿瘤<br>经验分享:2021年《国际期刊预警名单(试行)》正式发布。 International Journal of Clinical and Experimental Medicine (IJCEM)已不在该预警名单中。 具体内容请参照https://mp.weixin.qq.com/s/dEIsgG3tCZRoWQBZ8UEJQA, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6e982088871, createdName=agile, createdTime=Fri Dec 31 12:04:23 CST 2021, time=2021-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=944703, encodeId=090d944e0366, content=今年的第一期第二期文章还会被收录吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c0e2492369, createdName=1247f785m03(暂无昵称), createdTime=Tue Mar 02 11:16:07 CST 2021, time=2021-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582525, encodeId=3abb5825252f, content=我,不过文章数据确实不行。有没有知道被这个拒了之后还能投哪里<span class="quote">198syB63031(暂无昵称) 2019-12-21 发表::<br>有没有被这个杂志拒稿过的?</span>, beContent=198syB63031(暂无昵称) 2019-12-21 发表:: 有没有被这个杂志拒稿过的?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80c11717007, createdName=relic to Vivian827a006f, createdTime=Wed Jan 01 23:01:00 CST 2020, time=2020-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=911072, encodeId=c9509110e210, content=这个杂志PMC和Pubmed检索不到影响考博晋升吗,想问, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=54045173478, createdName=146e00b0m22(暂无昵称), createdTime=Sat Dec 26 12:38:39 CST 2020, time=2020-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=905359, encodeId=ed6090535948, content=online厚要多久才能开到检索证明, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200629/27edc3ca58794e0c8e3c7e54ded4a17a/1acf852649de425fbaf8af3ae4bc5b7b.jpg, createdBy=d8905201258, createdName=1473ceadm69(暂无昵称), createdTime=Sun Dec 06 10:10:03 CST 2020, time=2020-12-06, status=1, ipAttribution=)]
    2020-02-12 daidiu

    被拒了,自己感觉另一篇差一些的,还被另个高一些的杂志接收了

    5

    展开5条回复
  5. [GetPortalCommentsPageByObjectIdResponse(id=600644, encodeId=d29b600644e2, content=IJCEM会被踢吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200629/27edc3ca58794e0c8e3c7e54ded4a17a/1acf852649de425fbaf8af3ae4bc5b7b.jpg, createdBy=d8905201258, createdName=1473ceadm69(暂无昵称), createdTime=Wed May 27 13:23:11 CST 2020, time=2020-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586463, encodeId=99b058646305, content=被IJCEP拒了让转投这个,请问这俩差别大吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=186, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=17265265904, createdName=148110afm22暂无昵称, createdTime=Thu Mar 12 00:00:00 CST 2020, time=2020-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=901957, encodeId=478590195ec6, content=这个杂志录用了可以加急发吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=61ab1740098, createdName=呦宝贝, createdTime=Tue Nov 24 21:38:24 CST 2020, time=2020-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584635, encodeId=5a8a5846358e, content=被拒了,自己感觉另一篇差一些的,还被另个高一些的杂志接收了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/zoga7gvBpRvONqSypxjq5Adv6Mac2WEIKxV2jeVDxdZPtrLtlRQnX2iaWwpONcbXdmXqYqATkNiamEzUyNpaH52g/132, createdBy=f4ce1700659, createdName=daidiu, createdTime=Wed Feb 12 00:00:00 CST 2020, time=2020-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=913525, encodeId=2eea9135259b, content=投稿命中不容易, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210104/294dbbdf6b8c42efb140d9e70f3d35e6/85df95e80e0d44b8a95559af8d6adc7c.jpg, createdBy=37b35449803, createdName=dajunma, createdTime=Mon Jan 04 10:39:01 CST 2021, time=2021-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1179233, encodeId=05e311e923329, content=偏重的研究方向:肿瘤<br>经验分享:2021年《国际期刊预警名单(试行)》正式发布。 International Journal of Clinical and Experimental Medicine (IJCEM)已不在该预警名单中。 具体内容请参照https://mp.weixin.qq.com/s/dEIsgG3tCZRoWQBZ8UEJQA, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6e982088871, createdName=agile, createdTime=Fri Dec 31 12:04:23 CST 2021, time=2021-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=944703, encodeId=090d944e0366, content=今年的第一期第二期文章还会被收录吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c0e2492369, createdName=1247f785m03(暂无昵称), createdTime=Tue Mar 02 11:16:07 CST 2021, time=2021-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582525, encodeId=3abb5825252f, content=我,不过文章数据确实不行。有没有知道被这个拒了之后还能投哪里<span class="quote">198syB63031(暂无昵称) 2019-12-21 发表::<br>有没有被这个杂志拒稿过的?</span>, beContent=198syB63031(暂无昵称) 2019-12-21 发表:: 有没有被这个杂志拒稿过的?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80c11717007, createdName=relic to Vivian827a006f, createdTime=Wed Jan 01 23:01:00 CST 2020, time=2020-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=911072, encodeId=c9509110e210, content=这个杂志PMC和Pubmed检索不到影响考博晋升吗,想问, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=54045173478, createdName=146e00b0m22(暂无昵称), createdTime=Sat Dec 26 12:38:39 CST 2020, time=2020-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=905359, encodeId=ed6090535948, content=online厚要多久才能开到检索证明, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200629/27edc3ca58794e0c8e3c7e54ded4a17a/1acf852649de425fbaf8af3ae4bc5b7b.jpg, createdBy=d8905201258, createdName=1473ceadm69(暂无昵称), createdTime=Sun Dec 06 10:10:03 CST 2020, time=2020-12-06, status=1, ipAttribution=)]
    2021-01-04 dajunma

    投稿命中不容易

    5

    展开5条回复
  6. [GetPortalCommentsPageByObjectIdResponse(id=600644, encodeId=d29b600644e2, content=IJCEM会被踢吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200629/27edc3ca58794e0c8e3c7e54ded4a17a/1acf852649de425fbaf8af3ae4bc5b7b.jpg, createdBy=d8905201258, createdName=1473ceadm69(暂无昵称), createdTime=Wed May 27 13:23:11 CST 2020, time=2020-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586463, encodeId=99b058646305, content=被IJCEP拒了让转投这个,请问这俩差别大吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=186, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=17265265904, createdName=148110afm22暂无昵称, createdTime=Thu Mar 12 00:00:00 CST 2020, time=2020-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=901957, encodeId=478590195ec6, content=这个杂志录用了可以加急发吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=61ab1740098, createdName=呦宝贝, createdTime=Tue Nov 24 21:38:24 CST 2020, time=2020-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584635, encodeId=5a8a5846358e, content=被拒了,自己感觉另一篇差一些的,还被另个高一些的杂志接收了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/zoga7gvBpRvONqSypxjq5Adv6Mac2WEIKxV2jeVDxdZPtrLtlRQnX2iaWwpONcbXdmXqYqATkNiamEzUyNpaH52g/132, createdBy=f4ce1700659, createdName=daidiu, createdTime=Wed Feb 12 00:00:00 CST 2020, time=2020-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=913525, encodeId=2eea9135259b, content=投稿命中不容易, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210104/294dbbdf6b8c42efb140d9e70f3d35e6/85df95e80e0d44b8a95559af8d6adc7c.jpg, createdBy=37b35449803, createdName=dajunma, createdTime=Mon Jan 04 10:39:01 CST 2021, time=2021-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1179233, encodeId=05e311e923329, content=偏重的研究方向:肿瘤<br>经验分享:2021年《国际期刊预警名单(试行)》正式发布。 International Journal of Clinical and Experimental Medicine (IJCEM)已不在该预警名单中。 具体内容请参照https://mp.weixin.qq.com/s/dEIsgG3tCZRoWQBZ8UEJQA, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6e982088871, createdName=agile, createdTime=Fri Dec 31 12:04:23 CST 2021, time=2021-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=944703, encodeId=090d944e0366, content=今年的第一期第二期文章还会被收录吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c0e2492369, createdName=1247f785m03(暂无昵称), createdTime=Tue Mar 02 11:16:07 CST 2021, time=2021-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582525, encodeId=3abb5825252f, content=我,不过文章数据确实不行。有没有知道被这个拒了之后还能投哪里<span class="quote">198syB63031(暂无昵称) 2019-12-21 发表::<br>有没有被这个杂志拒稿过的?</span>, beContent=198syB63031(暂无昵称) 2019-12-21 发表:: 有没有被这个杂志拒稿过的?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80c11717007, createdName=relic to Vivian827a006f, createdTime=Wed Jan 01 23:01:00 CST 2020, time=2020-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=911072, encodeId=c9509110e210, content=这个杂志PMC和Pubmed检索不到影响考博晋升吗,想问, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=54045173478, createdName=146e00b0m22(暂无昵称), createdTime=Sat Dec 26 12:38:39 CST 2020, time=2020-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=905359, encodeId=ed6090535948, content=online厚要多久才能开到检索证明, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200629/27edc3ca58794e0c8e3c7e54ded4a17a/1acf852649de425fbaf8af3ae4bc5b7b.jpg, createdBy=d8905201258, createdName=1473ceadm69(暂无昵称), createdTime=Sun Dec 06 10:10:03 CST 2020, time=2020-12-06, status=1, ipAttribution=)]
    2021-12-31 agile

    偏重的研究方向:肿瘤
    经验分享:2021年《国际期刊预警名单(试行)》正式发布。 International Journal of Clinical and Experimental Medicine (IJCEM)已不在该预警名单中。 具体内容请参照https://mp.weixin.qq.com/s/dEIsgG3tCZRoWQBZ8UEJQA

    4

    展开4条回复
  7. [GetPortalCommentsPageByObjectIdResponse(id=600644, encodeId=d29b600644e2, content=IJCEM会被踢吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200629/27edc3ca58794e0c8e3c7e54ded4a17a/1acf852649de425fbaf8af3ae4bc5b7b.jpg, createdBy=d8905201258, createdName=1473ceadm69(暂无昵称), createdTime=Wed May 27 13:23:11 CST 2020, time=2020-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586463, encodeId=99b058646305, content=被IJCEP拒了让转投这个,请问这俩差别大吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=186, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=17265265904, createdName=148110afm22暂无昵称, createdTime=Thu Mar 12 00:00:00 CST 2020, time=2020-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=901957, encodeId=478590195ec6, content=这个杂志录用了可以加急发吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=61ab1740098, createdName=呦宝贝, createdTime=Tue Nov 24 21:38:24 CST 2020, time=2020-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584635, encodeId=5a8a5846358e, content=被拒了,自己感觉另一篇差一些的,还被另个高一些的杂志接收了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/zoga7gvBpRvONqSypxjq5Adv6Mac2WEIKxV2jeVDxdZPtrLtlRQnX2iaWwpONcbXdmXqYqATkNiamEzUyNpaH52g/132, createdBy=f4ce1700659, createdName=daidiu, createdTime=Wed Feb 12 00:00:00 CST 2020, time=2020-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=913525, encodeId=2eea9135259b, content=投稿命中不容易, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210104/294dbbdf6b8c42efb140d9e70f3d35e6/85df95e80e0d44b8a95559af8d6adc7c.jpg, createdBy=37b35449803, createdName=dajunma, createdTime=Mon Jan 04 10:39:01 CST 2021, time=2021-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1179233, encodeId=05e311e923329, content=偏重的研究方向:肿瘤<br>经验分享:2021年《国际期刊预警名单(试行)》正式发布。 International Journal of Clinical and Experimental Medicine (IJCEM)已不在该预警名单中。 具体内容请参照https://mp.weixin.qq.com/s/dEIsgG3tCZRoWQBZ8UEJQA, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6e982088871, createdName=agile, createdTime=Fri Dec 31 12:04:23 CST 2021, time=2021-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=944703, encodeId=090d944e0366, content=今年的第一期第二期文章还会被收录吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c0e2492369, createdName=1247f785m03(暂无昵称), createdTime=Tue Mar 02 11:16:07 CST 2021, time=2021-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582525, encodeId=3abb5825252f, content=我,不过文章数据确实不行。有没有知道被这个拒了之后还能投哪里<span class="quote">198syB63031(暂无昵称) 2019-12-21 发表::<br>有没有被这个杂志拒稿过的?</span>, beContent=198syB63031(暂无昵称) 2019-12-21 发表:: 有没有被这个杂志拒稿过的?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80c11717007, createdName=relic to Vivian827a006f, createdTime=Wed Jan 01 23:01:00 CST 2020, time=2020-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=911072, encodeId=c9509110e210, content=这个杂志PMC和Pubmed检索不到影响考博晋升吗,想问, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=54045173478, createdName=146e00b0m22(暂无昵称), createdTime=Sat Dec 26 12:38:39 CST 2020, time=2020-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=905359, encodeId=ed6090535948, content=online厚要多久才能开到检索证明, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200629/27edc3ca58794e0c8e3c7e54ded4a17a/1acf852649de425fbaf8af3ae4bc5b7b.jpg, createdBy=d8905201258, createdName=1473ceadm69(暂无昵称), createdTime=Sun Dec 06 10:10:03 CST 2020, time=2020-12-06, status=1, ipAttribution=)]
    2021-03-02 1247f785m03(暂无昵称)

    今年的第一期第二期文章还会被收录吗?

    4

    展开4条回复
  8. [GetPortalCommentsPageByObjectIdResponse(id=600644, encodeId=d29b600644e2, content=IJCEM会被踢吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200629/27edc3ca58794e0c8e3c7e54ded4a17a/1acf852649de425fbaf8af3ae4bc5b7b.jpg, createdBy=d8905201258, createdName=1473ceadm69(暂无昵称), createdTime=Wed May 27 13:23:11 CST 2020, time=2020-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586463, encodeId=99b058646305, content=被IJCEP拒了让转投这个,请问这俩差别大吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=186, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=17265265904, createdName=148110afm22暂无昵称, createdTime=Thu Mar 12 00:00:00 CST 2020, time=2020-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=901957, encodeId=478590195ec6, content=这个杂志录用了可以加急发吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=61ab1740098, createdName=呦宝贝, createdTime=Tue Nov 24 21:38:24 CST 2020, time=2020-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584635, encodeId=5a8a5846358e, content=被拒了,自己感觉另一篇差一些的,还被另个高一些的杂志接收了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/zoga7gvBpRvONqSypxjq5Adv6Mac2WEIKxV2jeVDxdZPtrLtlRQnX2iaWwpONcbXdmXqYqATkNiamEzUyNpaH52g/132, createdBy=f4ce1700659, createdName=daidiu, createdTime=Wed Feb 12 00:00:00 CST 2020, time=2020-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=913525, encodeId=2eea9135259b, content=投稿命中不容易, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210104/294dbbdf6b8c42efb140d9e70f3d35e6/85df95e80e0d44b8a95559af8d6adc7c.jpg, createdBy=37b35449803, createdName=dajunma, createdTime=Mon Jan 04 10:39:01 CST 2021, time=2021-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1179233, encodeId=05e311e923329, content=偏重的研究方向:肿瘤<br>经验分享:2021年《国际期刊预警名单(试行)》正式发布。 International Journal of Clinical and Experimental Medicine (IJCEM)已不在该预警名单中。 具体内容请参照https://mp.weixin.qq.com/s/dEIsgG3tCZRoWQBZ8UEJQA, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6e982088871, createdName=agile, createdTime=Fri Dec 31 12:04:23 CST 2021, time=2021-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=944703, encodeId=090d944e0366, content=今年的第一期第二期文章还会被收录吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c0e2492369, createdName=1247f785m03(暂无昵称), createdTime=Tue Mar 02 11:16:07 CST 2021, time=2021-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582525, encodeId=3abb5825252f, content=我,不过文章数据确实不行。有没有知道被这个拒了之后还能投哪里<span class="quote">198syB63031(暂无昵称) 2019-12-21 发表::<br>有没有被这个杂志拒稿过的?</span>, beContent=198syB63031(暂无昵称) 2019-12-21 发表:: 有没有被这个杂志拒稿过的?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80c11717007, createdName=relic to Vivian827a006f, createdTime=Wed Jan 01 23:01:00 CST 2020, time=2020-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=911072, encodeId=c9509110e210, content=这个杂志PMC和Pubmed检索不到影响考博晋升吗,想问, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=54045173478, createdName=146e00b0m22(暂无昵称), createdTime=Sat Dec 26 12:38:39 CST 2020, time=2020-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=905359, encodeId=ed6090535948, content=online厚要多久才能开到检索证明, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200629/27edc3ca58794e0c8e3c7e54ded4a17a/1acf852649de425fbaf8af3ae4bc5b7b.jpg, createdBy=d8905201258, createdName=1473ceadm69(暂无昵称), createdTime=Sun Dec 06 10:10:03 CST 2020, time=2020-12-06, status=1, ipAttribution=)]
    2020-01-01 relic to Vivian827a006f

    我,不过文章数据确实不行。有没有知道被这个拒了之后还能投哪里198syB63031(暂无昵称) 2019-12-21 发表::
    有没有被这个杂志拒稿过的?

    198syB63031(暂无昵称) 2019-12-21 发表:: 有没有被这个杂志拒稿过的?

    4

    展开4条回复
  9. [GetPortalCommentsPageByObjectIdResponse(id=600644, encodeId=d29b600644e2, content=IJCEM会被踢吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200629/27edc3ca58794e0c8e3c7e54ded4a17a/1acf852649de425fbaf8af3ae4bc5b7b.jpg, createdBy=d8905201258, createdName=1473ceadm69(暂无昵称), createdTime=Wed May 27 13:23:11 CST 2020, time=2020-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586463, encodeId=99b058646305, content=被IJCEP拒了让转投这个,请问这俩差别大吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=186, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=17265265904, createdName=148110afm22暂无昵称, createdTime=Thu Mar 12 00:00:00 CST 2020, time=2020-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=901957, encodeId=478590195ec6, content=这个杂志录用了可以加急发吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=61ab1740098, createdName=呦宝贝, createdTime=Tue Nov 24 21:38:24 CST 2020, time=2020-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584635, encodeId=5a8a5846358e, content=被拒了,自己感觉另一篇差一些的,还被另个高一些的杂志接收了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/zoga7gvBpRvONqSypxjq5Adv6Mac2WEIKxV2jeVDxdZPtrLtlRQnX2iaWwpONcbXdmXqYqATkNiamEzUyNpaH52g/132, createdBy=f4ce1700659, createdName=daidiu, createdTime=Wed Feb 12 00:00:00 CST 2020, time=2020-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=913525, encodeId=2eea9135259b, content=投稿命中不容易, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210104/294dbbdf6b8c42efb140d9e70f3d35e6/85df95e80e0d44b8a95559af8d6adc7c.jpg, createdBy=37b35449803, createdName=dajunma, createdTime=Mon Jan 04 10:39:01 CST 2021, time=2021-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1179233, encodeId=05e311e923329, content=偏重的研究方向:肿瘤<br>经验分享:2021年《国际期刊预警名单(试行)》正式发布。 International Journal of Clinical and Experimental Medicine (IJCEM)已不在该预警名单中。 具体内容请参照https://mp.weixin.qq.com/s/dEIsgG3tCZRoWQBZ8UEJQA, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6e982088871, createdName=agile, createdTime=Fri Dec 31 12:04:23 CST 2021, time=2021-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=944703, encodeId=090d944e0366, content=今年的第一期第二期文章还会被收录吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c0e2492369, createdName=1247f785m03(暂无昵称), createdTime=Tue Mar 02 11:16:07 CST 2021, time=2021-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582525, encodeId=3abb5825252f, content=我,不过文章数据确实不行。有没有知道被这个拒了之后还能投哪里<span class="quote">198syB63031(暂无昵称) 2019-12-21 发表::<br>有没有被这个杂志拒稿过的?</span>, beContent=198syB63031(暂无昵称) 2019-12-21 发表:: 有没有被这个杂志拒稿过的?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80c11717007, createdName=relic to Vivian827a006f, createdTime=Wed Jan 01 23:01:00 CST 2020, time=2020-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=911072, encodeId=c9509110e210, content=这个杂志PMC和Pubmed检索不到影响考博晋升吗,想问, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=54045173478, createdName=146e00b0m22(暂无昵称), createdTime=Sat Dec 26 12:38:39 CST 2020, time=2020-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=905359, encodeId=ed6090535948, content=online厚要多久才能开到检索证明, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200629/27edc3ca58794e0c8e3c7e54ded4a17a/1acf852649de425fbaf8af3ae4bc5b7b.jpg, createdBy=d8905201258, createdName=1473ceadm69(暂无昵称), createdTime=Sun Dec 06 10:10:03 CST 2020, time=2020-12-06, status=1, ipAttribution=)]
    2020-12-26 146e00b0m22(暂无昵称)

    这个杂志PMC和Pubmed检索不到影响考博晋升吗,想问

    4

    展开4条回复
  10. [GetPortalCommentsPageByObjectIdResponse(id=600644, encodeId=d29b600644e2, content=IJCEM会被踢吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200629/27edc3ca58794e0c8e3c7e54ded4a17a/1acf852649de425fbaf8af3ae4bc5b7b.jpg, createdBy=d8905201258, createdName=1473ceadm69(暂无昵称), createdTime=Wed May 27 13:23:11 CST 2020, time=2020-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586463, encodeId=99b058646305, content=被IJCEP拒了让转投这个,请问这俩差别大吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=186, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=17265265904, createdName=148110afm22暂无昵称, createdTime=Thu Mar 12 00:00:00 CST 2020, time=2020-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=901957, encodeId=478590195ec6, content=这个杂志录用了可以加急发吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=61ab1740098, createdName=呦宝贝, createdTime=Tue Nov 24 21:38:24 CST 2020, time=2020-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584635, encodeId=5a8a5846358e, content=被拒了,自己感觉另一篇差一些的,还被另个高一些的杂志接收了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/zoga7gvBpRvONqSypxjq5Adv6Mac2WEIKxV2jeVDxdZPtrLtlRQnX2iaWwpONcbXdmXqYqATkNiamEzUyNpaH52g/132, createdBy=f4ce1700659, createdName=daidiu, createdTime=Wed Feb 12 00:00:00 CST 2020, time=2020-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=913525, encodeId=2eea9135259b, content=投稿命中不容易, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210104/294dbbdf6b8c42efb140d9e70f3d35e6/85df95e80e0d44b8a95559af8d6adc7c.jpg, createdBy=37b35449803, createdName=dajunma, createdTime=Mon Jan 04 10:39:01 CST 2021, time=2021-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1179233, encodeId=05e311e923329, content=偏重的研究方向:肿瘤<br>经验分享:2021年《国际期刊预警名单(试行)》正式发布。 International Journal of Clinical and Experimental Medicine (IJCEM)已不在该预警名单中。 具体内容请参照https://mp.weixin.qq.com/s/dEIsgG3tCZRoWQBZ8UEJQA, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6e982088871, createdName=agile, createdTime=Fri Dec 31 12:04:23 CST 2021, time=2021-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=944703, encodeId=090d944e0366, content=今年的第一期第二期文章还会被收录吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c0e2492369, createdName=1247f785m03(暂无昵称), createdTime=Tue Mar 02 11:16:07 CST 2021, time=2021-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582525, encodeId=3abb5825252f, content=我,不过文章数据确实不行。有没有知道被这个拒了之后还能投哪里<span class="quote">198syB63031(暂无昵称) 2019-12-21 发表::<br>有没有被这个杂志拒稿过的?</span>, beContent=198syB63031(暂无昵称) 2019-12-21 发表:: 有没有被这个杂志拒稿过的?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80c11717007, createdName=relic to Vivian827a006f, createdTime=Wed Jan 01 23:01:00 CST 2020, time=2020-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=911072, encodeId=c9509110e210, content=这个杂志PMC和Pubmed检索不到影响考博晋升吗,想问, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=54045173478, createdName=146e00b0m22(暂无昵称), createdTime=Sat Dec 26 12:38:39 CST 2020, time=2020-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=905359, encodeId=ed6090535948, content=online厚要多久才能开到检索证明, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200629/27edc3ca58794e0c8e3c7e54ded4a17a/1acf852649de425fbaf8af3ae4bc5b7b.jpg, createdBy=d8905201258, createdName=1473ceadm69(暂无昵称), createdTime=Sun Dec 06 10:10:03 CST 2020, time=2020-12-06, status=1, ipAttribution=)]
    2020-12-06 1473ceadm69(暂无昵称)

    online厚要多久才能开到检索证明

    4

    展开4条回复
共500条页码: 2/50页10条/页
分享您的投稿经验,提升MI经验值,获取更多积分